Bioadvance is a Philadelphia-based early stage life science investing firm that collaborates with entrepreneurs in the mid-Atlantic region to develop robust companies dedicated to enhancing human health.
With a track record of investing in over 100 companies and achieving successful exits in various sectors, Bioadvance has facilitated the FDA approval of 11 products between 2013 and 2024.
Generated from the website